Medical Imaging Phantoms Market Trends

The growing prevalence of chronic diseases is a significant driver for market. These phantoms are essential tools for ensuring the accuracy and reliability of the diagnostic procedures associated with the diseases.

• For instance, according to the World Health Organization (WHO), in 2024, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. Further, it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.
  
• Phantoms are valuable tools for training healthcare professionals in epilepsy imaging. They provide a realistic simulation of brain structures and abnormalities associated with the disease, allowing clinicians to practice interpreting images and identifying seizure foci.
  
• For chronic conditions such as cancer, radiotherapy is a common treatment modality. Phantoms are used to optimize treatment plans by accurately measuring radiation dose delivery to tumors while minimizing exposure to surrounding healthy tissues. This is crucial for improving treatment outcomes and reducing side effects.
  
• Thus, phantoms optimize treatment planning and monitoring, supports research and development of new imaging technologies, ensures regulatory compliance, and ultimately improves patient outcomes, thereby escalating the growth of the market.